| Andrew Stanton Baker, DPT | |
|
2714 W Oxford Loop Ste 164, Oxford, MS 38655-5714 | |
| (662) 232-8949 | |
| Not Available |
| Full Name | Andrew Stanton Baker |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 11 Years |
| Location | 2714 W Oxford Loop Ste 164, Oxford, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124788989 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT5274 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Athletico Ltd | 4789602681 | 1957 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). Under the new agreement, Teva extended its marketing and distribution rights to include the Nordic and Baltic regions, previously held by Active Biotech. Active Biotech will receive a higher royalty rate for sales in these territories compared to the royalty rate set under the original licensing agreement signed in 2004 for sales in the rest of the world.
New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment.
The Centre for Therapeutic Target Validation (CTTV) has launched a new web platform for life-science researchers that helps them identify therapeutic targets for new and repurposed medicines. Today's launch underscores the CTTV's commitment to share its data openly to benefit the broader scientific community.
French and American researchers have developed a unique approach to drug design where an important neuron-signaling enzyme called acetylcholinesterase (AChE) acts as a microscopic vessel filled with reactant chemicals, to create its own, tailored therapeutic agent.
› Verified 2 days ago
| Provider Name | Athletico Ltd |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1477224814 PECOS PAC ID: 4789602681 Enrollment ID: O20211115001046 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). Under the new agreement, Teva extended its marketing and distribution rights to include the Nordic and Baltic regions, previously held by Active Biotech. Active Biotech will receive a higher royalty rate for sales in these territories compared to the royalty rate set under the original licensing agreement signed in 2004 for sales in the rest of the world.
New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment.
The Centre for Therapeutic Target Validation (CTTV) has launched a new web platform for life-science researchers that helps them identify therapeutic targets for new and repurposed medicines. Today's launch underscores the CTTV's commitment to share its data openly to benefit the broader scientific community.
French and American researchers have developed a unique approach to drug design where an important neuron-signaling enzyme called acetylcholinesterase (AChE) acts as a microscopic vessel filled with reactant chemicals, to create its own, tailored therapeutic agent.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Stanton Baker, DPT Po Box 1016, Oxford, MS 38655-1016 Ph: (662) 232-8949 | Andrew Stanton Baker, DPT 2714 W Oxford Loop Ste 164, Oxford, MS 38655-5714 Ph: (662) 232-8949 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). Under the new agreement, Teva extended its marketing and distribution rights to include the Nordic and Baltic regions, previously held by Active Biotech. Active Biotech will receive a higher royalty rate for sales in these territories compared to the royalty rate set under the original licensing agreement signed in 2004 for sales in the rest of the world.
New research has found that the availability of a portable eight-slice computed tomography (CT) scanner in an emergency room can significantly increase the number of stroke victims who receive a potentially life-saving treatment.
The Centre for Therapeutic Target Validation (CTTV) has launched a new web platform for life-science researchers that helps them identify therapeutic targets for new and repurposed medicines. Today's launch underscores the CTTV's commitment to share its data openly to benefit the broader scientific community.
French and American researchers have developed a unique approach to drug design where an important neuron-signaling enzyme called acetylcholinesterase (AChE) acts as a microscopic vessel filled with reactant chemicals, to create its own, tailored therapeutic agent.
› Verified 2 days ago
Mr. Andrew Ashby Buglewicz, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2205 Jefferson Davis Dr, Oxford, MS 38655 Phone: 662-238-2800 Fax: 662-238-2808 | |
Cecilia Escario, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Veterans Dr, Oxford, MS 38655 Phone: 662-259-5516 | |
Kenneth C Hill, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 300 Enterprise Dr Ste B, Oxford, MS 38655 Phone: 662-234-0010 Fax: 662-234-0017 | |
Cornerstone Rehabilitation Of Univ-oxf-laf Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1201a Office Park Dr, Oxford, MS 38655 Phone: 662-371-1987 Fax: 662-371-1989 | |
Mrs. Angela Arnold Forester, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2580 Jackson Ave W, Ste 38, Oxford, MS 38655 Phone: 662-232-8949 Fax: 662-232-8950 | |
Haley Paige Matkins Gaines, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 204 Enterprise Dr Unit 15, Oxford, MS 38655 Phone: 662-234-0010 | |
Endurance Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 2714 W Oxford Loop Ste 164, Oxford, MS 38655 Phone: 662-232-8949 Fax: 662-232-8950 |